OBJECTIVE: To evaluate the clinical and epidemiological profile of patients with valvular heart disease who arrived decompensated at the emergency department of a university hospital in Brazil. METHODS: A descriptive analysis of clinical and echocardiographic data of 174 patients with severe valvular disease, who were clinically decompensated and went to the emergency department of a tertiary cardiology hospital, in the State of São Paulo, in 2009. RESULTS: The mean age of participants was 56 ± 17 years and 54% were female. The main cause of valve disease was rheumatic in 60%, followed by 15% of degenerative aortic disease and mitral valve prolapse in 13%. Mitral regurgitation (27.5%) was the most common isolated valve disease, followed by aortic stenosis (23%), aortic regurgitation (13%) and mitral stenosis (11%). In echocardiographic data, the mean left atrial diameter was 48 ± 12 mm, 38 ± 12 mm for the left ventricular systolic diameter, and 54 ± 12 mm for the diastolic diameter; the mean ejection fraction was 56 ± 13%, and the mean pulmonary artery pressure was 53 ± 1 6 mmHg. Approximately half of patients (44%) presented atrial fibrillation, and over one third of them (37%) had already undergone another cardiac surgery. CONCLUSION: Despite increased comorbidities and age-dependent risk factors commonly described in patients with valvular heart disease, the clinical profile of patients arriving at the emergency department represented a cohort of rheumatic patients in more advanced stages of disease. These patients require priority care in high complexity specialized hospitals.
OBJECTIVE: To evaluate the clinical and epidemiological profile of patients with valvular heart disease who arrived decompensated at the emergency department of a university hospital in Brazil. METHODS: A descriptive analysis of clinical and echocardiographic data of 174 patients with severe valvular disease, who were clinically decompensated and went to the emergency department of a tertiary cardiology hospital, in the State of São Paulo, in 2009. RESULTS: The mean age of participants was 56 ± 17 years and 54% were female. The main cause of valve disease was rheumatic in 60%, followed by 15% of degenerative aortic disease and mitral valve prolapse in 13%. Mitral regurgitation (27.5%) was the most common isolated valve disease, followed by aortic stenosis (23%), aortic regurgitation (13%) and mitral stenosis (11%). In echocardiographic data, the mean left atrial diameter was 48 ± 12 mm, 38 ± 12 mm for the left ventricular systolic diameter, and 54 ± 12 mm for the diastolic diameter; the mean ejection fraction was 56 ± 13%, and the mean pulmonary artery pressure was 53 ± 1 6 mmHg. Approximately half of patients (44%) presented atrial fibrillation, and over one third of them (37%) had already undergone another cardiac surgery. CONCLUSION: Despite increased comorbidities and age-dependent risk factors commonly described in patients with valvular heart disease, the clinical profile of patients arriving at the emergency department represented a cohort of rheumaticpatients in more advanced stages of disease. These patients require priority care in high complexity specialized hospitals.
The rheumatic etiology prevails as the main cause of valvular heart disease in Brazil,( and it is quite different from Europe and the United States, where the disease is mainly caused by degenerative conditions.(The population is aging in Brazil. Life expectancy at birth, according to data from the Information Technology Department of the Unified Health System (DATASUS), is roughly 73 years( and this aging has increased the diagnosis of degenerative etiology valve diseases, frequently accompanied by age-dependent comorbidities.This kind of patient is a real challenge to the general practitioner at the front line of care, given comorbidities plus underlying valve disease make treatment complex, and clinical outcomes are not always satisfactory.In view of this increasing complexity, specialists in valve disease have proposed at cardiology associations a multidisciplinary professional team (the heart team) approach for these patients, including cardiologists, chest physicians, geriatrists, heart surgeons, dietitians, radiologists, hemodynamic specialists and psychologists, among others.University hospitals are essential parts of the Brazilian health system, because they are references for highly complex cases in the entire national territory. However, due to the difficulties in access found in our health system, patients who should receive preventive care at the initial stages of valve heart disease at primary care units eventually reach tertiary and quaternary hospitals at advanced stages of the valve heart condition, requiring urgent intervention through the emergency department.The clinical characteristics and comorbidities of patients with valve heart disease who arrive decompensated at the emergency department have not been acknowledged. Therefore, it is essential for the general practitioner to acknowledge the epidemiological, clinical and echocardiographic profile of individuals with valve disease who arrive at the emergency department.
OBJECTIVE
To evaluate the epidemiological, clinical and echocardiographic profile of patients with valvular heart disease who arrive decompensated at the emergency department of a national reference university hospital.
METHODS
A descriptive analysis of clinical and echocardiographic data of 174 consecutive patients with severe valve disease, who arrived clinically decompensated at the emergency department, and were admitted to a tertiary cardiology hospital in the State of São Paulo, in 2009.All patients included had valve heart disease as their main diagnosis and cause of their clinical instability. Regardless of the type of valve disease, it was confirmed by the clinical valve disease unit team, and through echocardiographic assessment. All patients were functional class III/IV of the New York Heart Association.The clinical profile variables collected upon admission were:AgeGenderUnderlying valve diseaseEtiology of valve disease (based on clinical history, physical exam and echocardiography)Comorbidities: hypertension defined as blood pressure >140×90mmHg or use of antihypertensive drugs; diabetes mellitus defined as need for oral hypoglycemic agents and/or insulin; coronary artery disease; peripheral artery disease or previous neurological disorderPrevious heart surgeryPresence of valve prosthesisAtrial fibrillation (paroxistical, persistent and permanent)Medication taken by patientThe echocardiogram after admission registered: left atrial and both ventricular diameters; pulmonary artery systolic pressure (PASP); diastolic function (ventricular filling pattern); left ventricular ejection fraction (LVEF); estimate of right ventricular function; and analysis of valves. PASP was classified into two groups: high pressure, if PASP >30mmHg, and normal, if PASP <30mmHg. LVEF >50% was considered normal and LVEF <50%, decreased.Continuous variables were expressed as mean and standard deviation (normal distribution), and median and interquartile variation (asymmetrical distribution). Categorical variables were expressed as absolute and relative frequencies. The study protocol was approved by the Research Project Analysis Ethics Committee (Cappesq) on April 7, 2010, with protocol number 0155/10.
RESULTS
Among the 174 patients evaluated, the mean age was 56±17 years and 54% were female. The main valve etiology was rheumatic in 60%, followed by degenerative disease in 15% of patients (Table 1). The most frequently observed isolated valve disease was mitral regurgitation (27.5%), followed by aortic stenosis (23%). In relation to comorbidities, 51% had hypertension, 16% diabetes mellitus and 44% atrial fibrillation. Over one third of patients had already been submitted to another heart valve surgery and 95% had a biological prosthesis. Valve prosthesis dysfunction was the reason for admission for 9.2%; the main prosthesis was mitral, in 8.1%, followed by the aortic. Associated coronary artery disease was found in 17% of patients (Table 1).
Table 1
Patients' characteristics
Clinical findings
Mean and/or %
Age, years
56±17
Female
54
Hypertension
51
Diabetes mellitus
16
Atrial fibrillation
44
Reoperations
37
Valve disease
Mitral regurgitation
27,5
Aortic stenosis
23
Aortic regurgitation
13
Mitral stenosis
11
Etiology
Rheumatic
60
Aortic degenerative disease
15
Mitral valve prolapse
13
Endocarditis
9
Others*
3
Bicuspid aortic disease, ischemic disease and aneurysm and aorta dissection.
Bicuspid aortic disease, ischemic disease and aneurysm and aorta dissection.Regarding medication use, 80% were on diuretics, 55% on angiotensin-converting enzyme inhibitors, 33% on aldosterone antagonists, 44% on digoxin, 35% on beta blockers, 17% on aspirin, 25% on anticoagulants and 10% on amiodarone (Table 2).
Table 2
Medication used
Medication
Use (%)
Diuretics
80
Angiotensin-converting enzyme inhibitors
55
Angiotensin II receptor inhibitors
12
Calcium antagonists*
13
Digoxin
44
Beta blockers**
35
Aldosterone antagonist
33
Aspirin
17
Anticoagulants
25
Statins
27
Amiodarone
10
Hydralazine/nitrate
12
The main calcium antagonist taken was amlodipine;
the main beta blocker taken was carvedilol.
The main calcium antagonist taken was amlodipine;the main beta blocker taken was carvedilol.As to echocardiographic parameters (Table 3), the mean left ventricle dimension on systole was 38±12mm, and on diastole, 54±12mm. Mean LVEF was 56±13%. LVEF was classified as normal (LVEF>50%) in 77%, and decreased (LVEF<50%) in 23%. Mean PASP was 53±6mmHg, in that 55% of patients had a high pulmonary pressure (PASP>30mmHg) and 45% had a PASP<30mmHg. All patients were in functional class III or IV upon admission at the emergency department and the main reason for clinical decompensation was progression of the uderlying disease. Most patients had already been assessed by specialists at the outpatient clinic, and over 90% of them were already programmed for surgery due to progression of symptoms and echocardiography parameters.
Table 3
Echocardiographic parameters
Echocardiography
Values
Left atrium, mm
48±12
LVSD, mm
38±12
LVDD, mm
54±12
LVEF, %
56±13
PASP, mmHg
53±16
LVSD: left ventricular systolic diameter LVDD: left ventricular diastolic diameter; LVEF: left ventricular ejection fraction; PASP: pulmonary artery systolic pressure.
LVSD: left ventricular systolic diameter LVDD: left ventricular diastolic diameter; LVEF: left ventricular ejection fraction; PASP: pulmonary artery systolic pressure.
DISCUSSION
The main findings of the present study were: most patients with valve disease seen at the emergency department had rheumatic etiology; despite the main rheumatic etiology, the mean age of patients was above what is expected for this etiology; a significant part of patients seen had already been submitted to heart surgery; most patients seen were already scheduled for surgery.In rheumatic disease, the eradication of the infectious condition of the oropharynx would abort the emergence of immune disease and its complications.( However, in Brazil, primary care and access to health services are far from ideal, and rheumatic fever still has a high incidence. In our study, in fact, the rheumatic etiology was the most frequent. In general, rheumaticpatients are affected at an earlier age (school and adolescence) and, depending on the degree of valve involvement, consequences can appear at very early ages. There is predominance in female patients and the mitral valve is the most affected.In our study, most patients were women and mitral involvement was very common. However, the mean age of patients was above expected (considering rheumatic etiology). We highlight that patients had more advanced stage valve disease characterized by previous valve surgery and the frequent presence of atrial fibrillation and pulmonary hypertension.In the natural history of valve heart disease, the presence of valve disease-related symptoms is the main indication for repair. However, some echocardiographic parameters, such as ventricular function, pulmonary artery pressure and ventricular diameters, are also taken into account to indicate intervention.( Particularly, atrial fibrillation and pulmonary hypertension also have prognostic meaning. Pulmonary artery pressure is related to an increased risk of death and heart failure.(Atrial fibrillation, which is responsible for reducing cardiac output and predisposes to thromboembolic events,( also is an independent predictor of risk of death in the postoperative period of heart surgery, as exposed in the STS risk score.(Another striking characteristic of this population was the number of previous surgeries that, in this case, can be explained by the rheumatic etiology, in which the first surgery occurred at a young age, with the preference of the organization for biological prostheses. This choice is guided by two main reasons: the chronic use of anticoagulants would make pregnancy difficult in women at child-bearing age given the medication is mandatory with a mechanical prosthesis, unlike bioprostheses; second, the difficult access to medical care and the low level of schooling would be inversely related to appropriate compliance to and control of oral anticoagulants.(Regarding surgery in youth, we know that the durability of a biological prosthesis can be of up to 15 to 20 years in the best scenarios, but its dysfunction may happen at any moment during follow-up. This fact would be one more factor to explain the high incidence of reoperations.The mean ventricular function was not as low as expected in a population with important symptoms (functional classes III/IV), but many cases were of individuals with single or combined mitral regurgitation, which knowingly overestimates ventricular function.Most patients had already been assessed by a specialist in the outpatient clinic and over 90% of them were already scheduled for surgery. However, due to the imbalance between demand and availability for intervention in a programmed surgical procedure, in many cases patients were on hold for treatment, and were followed by clinical outpatient care. During this period, many patients were eventually admitted to hospital in unfavorable conditions and at advanced stages of poor heart adaptation. Non-programmed surgery, as an emergency, is a reality in our country due to high demand, poor distribution and poor organization of the healthcare system. This delay has already been described in other centers in the world.(Surgery triggered through the emergency department is an independent variable for operative risk and, in the main heart surgery risk scores, such as the EuroSCORE, it represents an independent risk variable.(
LIMITATION
The present study is descriptive of one center and limited in time. There are no inferential possibilities. However, it adds relevant information on the “real world” given it was performed at a high complex valve heart disease reference center.
CONCLUSION
Despite increase in comorbidities and age-dependent risk factors commonly described in individuals with valvular heart disease, the clinical profile of patients who present at the emergency department represented a typical cohort of rheumaticpatients at more advanced stages of the disease. Mitral disease, young patients (in comparison to international valve disease cohorts), high rate of reoperations and pulmonary hypertension prevailed. These patients require priority care at high complexity specialized services.
Authors: Carlos Manuel de Almeida Brandão; Pablo Maria Alberto Pomerantzeff; Luciano Rapold Souza; Flávio Tarasoutchi; Max Grimberg; José Antonio Franchini Ramires; Sérgio Almeida de Oliveira Journal: Eur J Cardiothorac Surg Date: 2002-12 Impact factor: 4.191
Authors: Flávio Tarasoutchi; Marcelo Werterlund Montera; Max Grinberg; Daniel J Piñeiro; Carlos R Martinez Sánchez; Antonio Carlos Bacelar; Antonio Sérgio de Santis Andrade Lopes; João Ricardo Cordeiro Fernandes; Lucas José Tachotti Pires; Ricardo Casalino Sanches de Moraes; Tarso Augusto Duenhas Accorsi; Alexandre Siciliano Colafranceschi; Alberto Takeshi Kiyose; Alfredo Inácio Fiorelli; Antonio Carlos Bacelar; Antonio Sérgio de Santis Andrade Lopes; Auristela Isabel de Oliveira Ramos; Bertha Napchan Boer; Camilo Abdulmassih Neto; Carlos R Martínez Sánchez; Cesar Augusto Esteves; Clara Weksler; Daniel J Piñeiro; Dany David Kruczan; Eduardo Giusti Rossi; Evandro Tinoco Mesquita; Fabio Sândoli de Brito Junior; Fernando Bacal; Fernando Bosh; Fernando Florenzano Urzua; Fernando Moraes; Flávio Tarasoutchi; Francisco Diniz Affonso da Costa; Gilberto Venossi Barbosa; Guilherme Sobreira Spina; Henrique Murad; Humberto Martínez Hernández; João Ricardo Cordeiro Fernandes; José Armando Mangione; José Carlos Raimundo Brito; José Roberto Maldonado Murillo; Juan Carlos Plana; Juan José Paganini; Juan Krauss; Lídia Ana Zytynski Moura; Lucas José Tachotti Pires; Luiz Antonio Ferreira Carvalho; Luiz Francisco Cardoso; Marcelo Katz; Marcelo Luiz Campos Vieira; Marcelo Westerlund Montera; Márcia de Melo Barbosa; Mauricio de Rezende Barbosa; Max Grinberg; Omar Alonzo Villagrán; Pablo Maria A Pomerantzeff; Paulo de Lara Lavitola; Ricardo Casalino Sanches de Moraes; Rogério Eduardo Gomes Sarmento Leite; Roney Orismar Sampaio; Sérgio Franco; Silvia Marinho Martins; Solange Bordignon; Tarso Augusto Duenhas Accorsi; Tirone E David; Víctor Rojas Duré; Victor Rossei; Walkiria Samuel Ávila Journal: Arq Bras Cardiol Date: 2011 Impact factor: 2.000
Authors: Samer A M Nashef; François Roques; Linda D Sharples; Johan Nilsson; Christopher Smith; Antony R Goldstone; Ulf Lockowandt Journal: Eur J Cardiothorac Surg Date: 2012-02-29 Impact factor: 4.191
Authors: Andrea Barbieri; Francesca Bursi; Francesco Grigioni; Christophe Tribouilloy; Jean Francois Avierinos; Hector I Michelena; Dan Rusinaru; Catherine Szymansky; Antonio Russo; Rakesh Suri; Maria Letizia Bacchi Reggiani; Angelo Branzi; Maria Grazia Modena; Maurice Enriquez-Sarano Journal: Eur Heart J Date: 2010-09-08 Impact factor: 29.983
Authors: Sean M O'Brien; David M Shahian; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson Journal: Ann Thorac Surg Date: 2009-07 Impact factor: 4.330
Authors: Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Deborah Carvalho Malta; Andreia Biolo; Bruno Ramos Nascimento; Maria de Fatima Marinho de Souza; Andrea Rocha De Lorenzo; Antonio Aurélio de Paiva Fagundes Júnior; Beatriz D Schaan; Fábio Morato de Castilho; Fernando Henpin Yue Cesena; Gabriel Porto Soares; Gesner Francisco Xavier Junior; Jose Augusto Soares Barreto Filho; Luiz Guilherme Passaglia; Marcelo Martins Pinto Filho; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Paolo Blanco Villela; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Pablo Perel; Gregory A Roth; Antonio Luiz Pinho Ribeiro Journal: Arq Bras Cardiol Date: 2022-01 Impact factor: 2.000
Authors: Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Andreia Biolo; Bruno Ramos Nascimento; Deborah Carvalho Malta; Maria de Fatima Marinho de Souza; Gabriel Porto Soares; Gesner Francisco Xavier Junior; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Odilson Marcos Silvestre; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Gregory A Roth; Antonio Luiz Pinho Ribeiro Journal: Arq Bras Cardiol Date: 2020-09 Impact factor: 2.667